307 related articles for article (PubMed ID: 22122292)
21. Parental anxiety as a predictor of medication and CBT response for anxious youth.
Gonzalez A; Peris TS; Vreeland A; Kiff CJ; Kendall PC; Compton SN; Albano AM; Birmaher B; Ginsburg GS; Keeton CP; March J; McCracken J; Rynn M; Sherrill J; Walkup JT; Piacentini J
Child Psychiatry Hum Dev; 2015 Feb; 46(1):84-93. PubMed ID: 24610431
[TBL] [Abstract][Full Text] [Related]
22. Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.
Halldorsdottir T; Ollendick TH; Ginsburg G; Sherrill J; Kendall PC; Walkup J; Sakolsky DJ; Piacentini J
J Clin Child Adolesc Psychol; 2015; 44(6):985-91. PubMed ID: 25310142
[TBL] [Abstract][Full Text] [Related]
23. Combining CBT and sertraline does not enhance outcomes for anxious youth: a double-blind randomised controlled trial.
Hudson JL; McLellan LF; Eapen V; Rapee RM; Wuthrich V; Lyneham HJ
Psychol Med; 2023 Apr; 53(5):1741-1749. PubMed ID: 34463234
[TBL] [Abstract][Full Text] [Related]
24. Trajectories of change in youth anxiety during cognitive-behavior therapy.
Peris TS; Compton SN; Kendall PC; Birmaher B; Sherrill J; March J; Gosch E; Ginsburg G; Rynn M; McCracken JT; Keeton CP; Sakolsky D; Suveg C; Aschenbrand S; Almirall D; Iyengar S; Walkup JT; Albano AM; Piacentini J
J Consult Clin Psychol; 2015 Apr; 83(2):239-52. PubMed ID: 25486372
[TBL] [Abstract][Full Text] [Related]
25. Naturalistic follow-up of youths treated for pediatric anxiety disorders.
Ginsburg GS; Becker EM; Keeton CP; Sakolsky D; Piacentini J; Albano AM; Compton SN; Iyengar S; Sullivan K; Caporino N; Peris T; Birmaher B; Rynn M; March J; Kendall PC
JAMA Psychiatry; 2014 Mar; 71(3):310-8. PubMed ID: 24477837
[TBL] [Abstract][Full Text] [Related]
26. Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS).
Rabner J; Olino TM; Albano AM; Keeton CP; Sakolsky D; Birmaher B; Piacentini J; Peris TS; Compton SN; Gosch E; Ginsburg GS; Pinney EL; Kendall PC
J Child Psychol Psychiatry; 2024 Jul; 65(7):910-920. PubMed ID: 38217328
[TBL] [Abstract][Full Text] [Related]
27. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
28. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).
Kennard B; Silva S; Vitiello B; Curry J; Kratochvil C; Simons A; Hughes J; Feeny N; Weller E; Sweeney M; Reinecke M; Pathak S; Ginsburg G; Emslie G; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1404-11. PubMed ID: 17135985
[TBL] [Abstract][Full Text] [Related]
29. The Effects of Youth Anxiety Treatment on School Impairment: Differential Outcomes Across CBT, Sertraline, and their Combination.
Sanchez AL; Comer JS; Coxe S; Albano AM; Piacentini J; Compton SN; Ginsburg GS; Rynn MA; Walkup JT; Sakolsky DJ; Birmaher B; Kendall PC
Child Psychiatry Hum Dev; 2019 Dec; 50(6):940-949. PubMed ID: 31087216
[TBL] [Abstract][Full Text] [Related]
30. Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders.
Cervin M; Storch EA; Piacentini J; Birmaher B; Compton SN; Albano AM; Gosch E; Walkup JT; Kendall PC
J Child Psychol Psychiatry; 2020 Apr; 61(4):492-502. PubMed ID: 31471911
[TBL] [Abstract][Full Text] [Related]
31. Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.
Compton SN; Walkup JT; Albano AM; Piacentini JC; Birmaher B; Sherrill JT; Ginsburg GS; Rynn MA; McCracken JT; Waslick BD; Iyengar S; Kendall PC; March JS
Child Adolesc Psychiatry Ment Health; 2010 Jan; 4():1. PubMed ID: 20051130
[TBL] [Abstract][Full Text] [Related]
32. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
[TBL] [Abstract][Full Text] [Related]
33. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults.
Schuurmans J; Comijs H; Emmelkamp PM; Gundy CM; Weijnen I; van den Hout M; van Dyck R
Am J Geriatr Psychiatry; 2006 Mar; 14(3):255-63. PubMed ID: 16505130
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Treatment Expectations on Exposure Process and Treatment Outcome in Childhood Anxiety Disorders.
Wu MS; Caporino NE; Peris TS; Pérez J; Thamrin H; Albano AM; Kendall PC; Walkup JT; Birmaher B; Compton SN; Piacentini J
J Abnorm Child Psychol; 2020 Jan; 48(1):79-89. PubMed ID: 31313062
[TBL] [Abstract][Full Text] [Related]
35. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
[TBL] [Abstract][Full Text] [Related]
36. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety.
Strawn JR; Mills JA; Suresh V; Peris TS; Walkup JT; Croarkin PE
J Affect Disord; 2022 Feb; 298(Pt A):292-300. PubMed ID: 34728290
[TBL] [Abstract][Full Text] [Related]
37. Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms.
Hale AE; Ginsburg GS; Chan G; Kendall PC; McCracken JT; Sakolsky D; Birmaher B; Compton SN; Albano AM; Walkup JT
J Clin Child Adolesc Psychol; 2018; 47(1):94-104. PubMed ID: 28278599
[TBL] [Abstract][Full Text] [Related]
38. Long-term effectiveness and prediction of treatment outcome in cognitive behavioral therapy and sertraline for late-life anxiety disorders.
Schuurmans J; Comijs H; Emmelkamp PM; Weijnen IJ; van den Hout M; van Dyck R
Int Psychogeriatr; 2009 Dec; 21(6):1148-59. PubMed ID: 19860993
[TBL] [Abstract][Full Text] [Related]
39. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
March J; Silva S; Vitiello B;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1393-403. PubMed ID: 17135984
[TBL] [Abstract][Full Text] [Related]
40. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.
Kelly JM; Jakubovski E; Bloch MH
J Clin Psychiatry; 2015 Mar; 76(3):267-78. PubMed ID: 25562579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
